The ENT Knife market outlook remains robust, driven by rising prevalence of chronic ear, nose, and throat disorders, technological advancements in minimally invasive procedures, and an aging global population. Market attractiveness is underscored by high unmet demand in emerging economies and favorable reimbursement policies in developed regions. Competitive intensity is moderate, with established players dominating through R&D investments and strategic partnerships, while niche players focus on cost-effective alternatives. Long-term growth is projected at a CAGR of 6.8% through 2030, supported by innovations in precision instruments and digital integration. The innovation landscape is dynamic, with a shift toward smart ENT devices leveraging AI and IoT for enhanced surgical outcomes. Demand-supply balance remains stable, though raw material shortages and regulatory delays pose intermittent risks. Key threats include stringent compliance costs, economic volatility impacting healthcare budgets, and potential product liability claims. Strategic foresight in R&D and agile supply chain management will be critical for sustaining market relevance.